webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene

  CAS No.: 160854-54-6   Cat No.: BADC-00461   Purity: ≥98% 4.5  

4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene is a thiol-reactive ADC linker offering a cleavable disulfide bond for controlled drug release. It facilitates amine-thiol crosslinking in antibody-drug conjugates, enabling targeted payload delivery under reductive tumor environments.

4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene

Structure of 160854-54-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C17H14N2O4S2
Molecular Weight
374.43
Shipping
Room temperature

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(2,5-dioxopyrrolidin-1-yl) 4-[(pyridin-2-yldisulfanyl)methyl]benzoate;
IUPAC Name
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)C2=CC=C(C=C2)CSSC3=CC=CC=N3
InChI
InChI=1S/C17H14N2O4S2/c20-15-8-9-16(21)19(15)23-17(22)13-6-4-12(5-7-13)11-24-25-14-3-1-2-10-18-14/h1-7,10H,8-9,11H2
InChIKey
VNWUUFREFCAFEV-UHFFFAOYSA-N
Appearance
Soild powder
Shipping
Room temperature

4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene, often referred to as SPDP, serves as a versatile cross-linking reagent with multifaceted applications in diverse biochemical settings. Here are four key applications of SPDP, presented with high perplexity and burstiness:

Protein-Protein Conjugation: SPDP emerges as a pivotal tool for covalently joining distinct proteins, opening avenues to investigate intricate protein-protein interactions. Through the establishment of steadfast disulfide bonds between proteins, researchers orchestrate functional protein complexes tailored for biochemical assays. This method is indispensable in unraveling the nuanced functional dynamics of protein associations within cellular processes.

Antibody Labeling: Delving into the realm of antibody labeling, SPDP plays a pivotal role in affixing antibodies with a spectrum of tags like enzymes, fluorescent dyes, or radioactive labels. This strategic maneuver enables the creation of antibody conjugates instrumental in diagnostic assays, flow cytometry, and imaging modalities. The precision inherent in the conjugation process upholds the biological activity of the antibody, ensuring the generation of dependable results.

Drug Delivery Systems: Embarking on the frontier of targeted drug delivery, SPDP facilitates the construction of tailored drug delivery systems by tethering therapeutic agents to targeting molecules, such as antibodies or peptides. This innovative approach bolsters the precise conveyance of drugs to specific cells or tissues, enhancing therapeutic efficacy while mitigating side effects. Such targeted systems prove exceptionally valuable in oncology and other domains of precision medicine.

Surface Immobilization: Leveraging the prowess of SPDP, researchers can immobilize biomolecules on solid substrates for a myriad of bioanalytical and biosensing endeavors. By affixing proteins, peptides, or other species onto surfaces, scientists fashion biosensors indispensable for detecting specific analytes. This capability is pivotal in realms spanning diagnostics, environmental surveillance, and biotechnological exploration, fostering the development of high-throughput screening methodologies.

1. Bioconjugation of ribonuclease A: a detailed chromatographic and mass spectrometric analysis of chemical modification by a cross-linking reagent
G H Lang, L S Nichols, D E Richardson, D H Powell, J R Eyler, T J Méndez, J V Johnson Bioconjug Chem . 2000 Mar-Apr;11(2):182-94. doi: 10.1021/bc990117g.
The modification of ribonuclease A with the heterobifunctional cross-linker, 4-succinimdyloxycarbonyl-methyl-alpha-[2-pyridyldithio]-toluene (SMPT) is described. RNase A has 11 potential sites of modification by the SMPT reagent. Tracking the two-dimensional separation and proteolytic digestion of SMPT-modified RNase A with ESI/FTICR-MS and HPLC/ESI/QIT-MS demonstrates the detailed information about number of SMPT modifications and sites of modification that can be obtained by application of these techniques. Analysis of native and modified RNase A tryptic digests by ESI/FTICR-MS resulted in the identification of the sites of modification. Semiquantitative results of the reactivity of certain lysine residues toward the coupling reagent SMPT are presented. Two sites (lysines 1 and 37) are highly reactive, while three sites (lysines 41, 61, and 104) appear to be unreactive toward SMPT under the conditions used. Experimental results demonstrate that quantitative comparison of relative intensities of peptide sequences of different charge states is not possible. No correlation was found between number of basic residues and sensitivity to detection. Digestion of the modified and unmodified RNase A by subtilisin followed by examination by HPLC/ESI/QIT-MS and MS(n) enabled further investigation of modification on lysines 1 and 7, including modification at the epsilon- and alpha-amino positions on lysine 1.
2. The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond
E S Vitetta, P Knowles, V Ghetie, J W Uhr, P Thorpe, M A Ghetie J Immunol Methods . 1991 Sep 13;142(2):223-30. doi: 10.1016/0022-1759(91)90110-2.
The large scale preparation of two second generation immunotoxins containing murine monoclonal antibodies and deglycosylated ricin A chain is described. The procedure for the preparation of immunotoxins consists of the derivatization of antibody with SMPT and reduction of dgA with DTT followed by their reaction to establish a hindered interchain disulfide bond. The purification of the immunotoxin includes affinity chromatography on Blue-Sepharose to remove the free antibody and gel filtration on Sephacryl S-200HR to remove any high molecular weight material and free dgA. The two immunotoxins were prepared by GLP procedures and tested for yield, composition, purity, sterility and biological activity.
3. Quantitative analysis of derivatized proteins prepared with pyridyl disulfide-containing cross-linkers by high-performance liquid chromatography
B H Woo, D H Na, K C Lee Bioconjug Chem . 1999 Mar-Apr;10(2):306-10. doi: 10.1021/bc980029g.
Determination of the introduced moieties into derivatized proteins is an essential step in the preparation and quality control of chemically defined immunoconjugates. For the derivatized proteins using pyridyl disulfide-containing cross-linkers such as N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP) and 4-succinimidyloxycarbonyl-alpha-methyl-alpha-(2-pyridyldithio)tolu ene (SMPT), the derivatization degree (ratio of pyridyl disulfide moieties to protein) has been traditionally determined by measuring the absorbance of both the derivatized protein and 2-thiopyridone (2-TP) released from the dithiothreitol (DTT) treatment (spectrophotometric method). This method, however, causes several problems including false high and low determinations of the protein and 2-TP, respectively, low selectivity, poor reproducibility, and relatively large amounts of sample consumption. A quantitative determination method of the derivatization ratios using bovine serum albumin derivatized with SPDP and SMPT as the model system has been developed. The concentration of protein and 2-TP released from the DTT treatment of derivatized proteins was determined directly without consideration of different reagents used and their concentrations. The present HPLC method was proved to be better in terms of accuracy, selectivity, and reproducibility with micro sample consumption. Moreover, this HPLC method can be directly applied to all derivatized proteins prepared with pyridyl disulfide-containing cross-linkers.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: MC-Gly-Gly-Phe | Boc-Ser(O-propargyl)-OH | m-PEG2-NHS ester | MC-Gly-Gly-Phe-Boc | MC-Gly-Gly-Phe-Gly | TCO-GK-PEG4-NHS ester | Fmoc-Val-Ala-PAB-PFP | MMAD | SPDMB | 2,5-dioxopyrrolidin-1-yl 15-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3,6,9-trioxa-12-azapentadecan-1-oate | 4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene
Send Inquiry
Verification code
Inquiry Basket